Stephen T Oh, MD, PhD¹, Srdan Verstovsek, MD, PhD², Jason Gotlib, MD, MS³, Vikas Gupta, MD, FRCP, FRCPath⁴, Uwe Platzbecker, MD⁵, Heinz Gisslinger, MD^6*, Timothy Devos, MD, PhD⁷, Jean-Jacques Kiladjian, MD⁸, Donal P. McLornan, MD, PhD^9*, Andrew Charles Perkins, MBBS, PhD¹⁰, Maria Laura Fox, MD^11*, Mary Frances McMullin, MD, FRCPath, FRCP¹², Adam J Mead, MD PhD^13,14, Miklos Egyed, MD, PhD^15*, Jiri Mayer, Prof, MD^16,17*, Tomasz Sacha, MD, PhD^18*, Jun Kawashima, MD^19*, Mei Huang, MS^19*, Bryan Strouse, MSc^19* and Ruben Mesa, MD, FACP²⁰

¹Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO
²MD Anderson Cancer Center, University of Texas, Houston, TX
³Stanford Cancer Institute, Stanford, CA
⁴Division of Medical Oncology and Hematology, University Health Network, Toronto, ON, Canada
⁵Department for Hematology, Cell Therapy and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany
⁶Medical University Vienna, Vienna, Austria
⁷University Hospitals Leuven and Laboratory of Molecular Immunology (Rega Institute), KU Leuven, Leuven, Belgium
⁸Université de Paris, AP-HP, Hôpital Saint-Louis, Centre d’Investigations Cliniques, Paris, France
⁹Haematology Department, Guy's and St Thomas' NHS Trust, London, United Kingdom
¹⁰Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia
¹¹University Hospital Vall d’Hebron, Barcelona, Spain
¹²Centre for Medical Education, Queen's University, Belfast, United Kingdom
¹³University of Oxford, Oxford, United Kingdom
¹⁴Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
¹⁵Somogy County Mór Kaposi General Hospital, Kaposvár, Hungary
¹⁶Hematology and Oncology, University Hospital Brno, Czech Republic, Brno, Czech Republic
¹⁷Masaryk University, Brno, Czech Republic
¹⁸Jagiellonian University Hospital, Kraków, Poland
¹⁹Sierra Oncology Inc., San Mateo, CA
²⁰UT Health San Antonio Cancer Center, San Antonio, TX

Gu Wenjing, MD^1*, Yuhui Zhang^2*, Renchi Yang, MD^3*, Jie Bai, MD², Rongfeng Fu, MD^4* and Lei Zhang, MD^4*

¹State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
²Department of Hematology, The Second Hospital of Tianjin Medical University, Tianjin, China
³State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China
⁴CAMS Key Laboratory of Gene Therapy for Blood Diseases, Tianjin Key Laboratory of Gene Therapy for Blood Diseases, Tianjin, China

Adrian Mosquera Orgueira^1*, Manuel Perez Encinas, MD^2*, Alberto Hernández Sánchez, MD^3*, Teresa González, PhD^4*, Eduardo Arellano-Rodrigo, MD^5*, Javier Martinez Martínez Elicegui^6*, Angela Villaverde Ramiro^7*, Jose Maria Raya Sanchez, MD, PhD^8*, Rosa Ayala, MD, PhD^9*, Francisca Ferrer Marin, MD, PhD¹⁰, Maria Laura Fox, MD^11*, Patricia Velez Tenza^12*, Elvira Mora Casterá, MD^13*, Blanca Xicoy, MD^14*, Maria Isabel Mata Vazquez, MD^15*, María García Fortes^16*, Anna Angona, MD^17*, Beatriz Cuevas, MD^18*, María Alicia Senin, MD^19*, Angel Ramírez Payer, MD^20*, María José Ramírez^21*, Raul Perez Lopez, MD, PhD^22*, Sonia González de Villambrosia, MD^23*, Clara Martínez^24*, María Teresa Gómez-Casares, MD, PhD^25*, Carmen Garcia-Hernandez, MD^26*, Mercedes Gasior Kabat, MD^27*, Beatriz Bellosillo^28*, Juan Luis Steegmann²⁹, Alberto Alvarez-Larran, MD, PhD^30*, Jesús María Hernández-Rivas, MD, PhD³¹ and Juan Carlos Hernandez Boluda, MD, PhD^32*

¹Complexo Hospitalario Universitario de Santiago de Compostela (CHUS), SERGAS, SANTIAGO DE COMPOSTELA, Spain
²Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain
³Hematology Department, University Hospital of Salamanca, Salamanca, Spain
⁴University Hospital of Salamanca, Salamanca, Spain
⁵Hospital Clinic de Barcelona- GEMFIN, Barcelona, Spain
⁶Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain
⁷Molecular Genetics in Oncohematology, Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain
⁸Department of Hematology, Hospital Universitario de Canarias, Tenerife, Spain, La Laguna, Spain
⁹Hematology Department, Hospital Universitario 12 de Octubre, MADRID, Spain
¹⁰Servicio de Hematología y Oncología Médica. H.U. Morales Meseguer. Centro Regional de Hemodonación. Universidad de Murcia. IMIB-Arrixaca, Murcia, Spain
¹¹Hematology Department, Hospital Universitario Vall d'Hebron, Barcelona, Spain
¹²Hospital Del Mar, Barcelona, Spain
¹³Dept. of Hematology, Hospital Universitario y Politécnico La Fe, Valencia, Spain
¹⁴HU German Trias i Pujol - Institut Català d' Oncologia, Barcelona, Spain
¹⁵Hospital Costa del Sol, Malaga, ESP
¹⁶Hospital Virgen de la Victoira, Malaga, Spain
¹⁷HU Dr. J Trueta - Institut Català d'Oncologia, Girona, Spain
¹⁸Hematology, Hospital Universitario de Burgos, BURGOS, ESP
¹⁹Hospital Duran i Reynals, Institut Catalá dÓncologia, L´Hospitalet de LLobregat., ESP
²⁰Hospital Universitario Central de Asturias, Oviedo, Spain
²¹Hematology Department, Hospital de Jerez de la Frontera, Jerez, Spain
²²HU Virgen de la Arrixaca, Murcia, Spain
²³Hematology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain
²⁴Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
²⁵Servicio de Hematología, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain
²⁶Hospital General de Alicante, Alicante, Spain
²⁷Hospital Universitario La Paz, Madrid, ESP
²⁸Hospital del Mar, Barcelona, Spain
²⁹University Hospital of La Princesa, Madrid, Spain
³⁰Hematology Department, Hospital Clínic, Barcelona, Spain
³¹HARMONY, Salamanca, Salamanca, Spain
³²Department of Hematology, Hospital Clínico Universitario de Valencia, Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain

Nico Gagelmann^1*, Anita Badbaran^1*, Rachel Beth Salit, MD^2*, Thomas Schroeder³, Carmelo Gurnari, MD⁴, Simona Pagliuca, MD, PhD⁵, Arnold Ganser, MD⁶, Christina Rautenberg, MD^7*, Bruno Cassinat, PharmD, PhD⁸, Felicitas R Thol, MD⁹, Christine Wolschke, MD^10*, Marie Robin, MD, PhD¹¹, Michael Heuser, MD⁶, Marie Thérèse Rubio, MD, PhD^12*, Jaroslaw P. Maciejewski, MD, PhD, FACP¹³, Hans Christian Reinhardt, MD¹⁴, Bart L. Scott, MD² and Nicolaus Kroeger, MD¹⁵

¹University Medical Center Hamburg-Eppendorf, Department of Stem Cell Transplantation, Hamburg, Germany
²Fred Hutchinson Cancer Research Center, Seattle, WA
³Dept. of Bone Marrow Transplantation, University Hospital Essen, Essen, Germany
⁴Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
⁵Hematology Department, University Hospital of Nancy, Vandoeuvre, France
⁶Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
⁷Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany
⁸INSERM UMR 1131, Institut de Recherche Saint-Louis, Paris, France
⁹Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hanover, Germany
¹⁰Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
¹¹Hopital Saint-Louis, Paris Cedex 10, France
¹²Service Hématologie, CHRU Brabois, Nancy, France
¹³Translational Hematology and Oncology Research, Cleveland Clinic Foundation/ Taussig Cancer Institute, Cleveland, OH
¹⁴Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany
¹⁵University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Hélène Pasquer, MSc^1,2*, Rafael Daltro De Oliveira, MD^2*, Juliette Soret, MD^2*, Nabih Maslah, PharmD, PhD^3,4*, Lin-Pierre Zhao, MD^2*, Clemence Marcault, MD^2*, Marine Cazaux, PhD^2*, Nicolas Gauthier, MD^2*, Emmanuelle Verger, PhD^3,4*, Nathalie Parquet, MD^5*, William Vainchenker, MD, PhD^5*, Emmanuel Raffoux^5*, Stephane Giraudier, MD PhD^3,4*, Bruno Cassinat, PharmD, PhD^3,4, Jean-Jacques Kiladjian, MD^2,4 and Lina Benajiba, MD, PhD^1,2

¹INSERM UMR 944, Institut de Recherche Saint-Louis, Paris, France
²Centre d’Investigations Cliniques, INSERM CIC 1427, Université Paris Cité, APHP, Hôpital Saint-Louis, Paris, France
³Laboratoire de Biologie Cellulaire, Université Paris Cité, APHP, Hôpital Saint-Louis, Paris, France
⁴INSERM UMR 1131, Institut de Recherche Saint-Louis, Paris, France
⁵Département d’hématologie et d’Immunologie, Université Paris Cité, APHP, Hôpital Saint-Louis, Paris, France

Paola Guglielmelli, MD, PhD¹, Fiorenza Irushani Vanderwert, BiSc^2*, Simone Romagnoli, PhD^2*, Giacomo Coltro, MD^2*, Giuseppe Gaetano Loscocco, MD^2*, Francesco Mannelli, MD^2*, Laura Calabresi, PhD^2*, Giulia Gentili, BiSc Stud^3*, Giada Rotunno, PhD^2*, Niccolò Bartalucci, PhD, BSc^2*, Valentina Boldrini, MD^2*, Emanuela Sant'Antonio^4*, Danilo Tarantino, PhD^2*, Marco Pieraccioli^5* and Alessandro Vannucchi, MD²

¹CRIMM, Center of Research and Innovation of Myeloproliferative Neoplasms, University of Florence, AOU Careggi, Florence, Italy
²CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, University of Florence, AOU Careggi, Florence, Italy
³CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, University of Florence, Florence, Italy
⁴University of Siena, GENOMEC Doctorate School, Siena, Italy
⁵Dept Neurosciences, Sect Human Anatomy, Catholic University of the Sacred Heart, Rome, Italy